1350 HOST-SPECIFIC FACTORS INDEPENDENT OF IL28B GENOTYPE PREDICTING TREATMENT OUTCOME OF INDIVIDUALIZED THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 INFECTION

ETR 4/31 (13%) 20/53 (38%) 84/100 (84%) 184/192 (96%) 4/57 (7%) 155/176 (88%) SVR 2/4 (50%) 13/20 (65%) 51/84 (61%) 143/184 (78%) 1/4 (25%) 100/155 (65%) Relapse 2/4 (50%) 7/20 (35%) 27/84 (32%) 40/184 (22%) 2/4 (50%) 47/155 (30%) CC 0/1 0/3 4/13 (31%) 22/91 (24%) 0/0 15/49 (31%) CT 2/3 (67%) 6/13 (46%) 14/47 (30%) 14/72 (19%) 2/3 (67%) 23/81 (28%) TT 0/0 1/4 (25%) 6/19 (32%) 1/9 (11%) 0/1 6/17 (35%)